Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 25;16(6):e0252309.
doi: 10.1371/journal.pone.0252309. eCollection 2021.

Frequency, timing and risk factors for primary maternal cytomegalovirus infection during pregnancy in Quebec

Safari Joseph Balegamire  1   2 , Christian Renaud  2   3 , Benoît Mâsse  1   4 , Kate Zinszer  1   5 , Soren Gantt  2   3 , Yves Giguere  6   7 , Jean-Claude Forest  6   7 , Isabelle Boucoiran  1   2   8
Affiliations

Frequency, timing and risk factors for primary maternal cytomegalovirus infection during pregnancy in Quebec

Safari Joseph Balegamire et al. PLoS One. .

Abstract

Introduction: Maternal Cytomegalovirus (CMV) infection in the first trimester (T1) of pregnancy is a public health concern, as it increases the risk of severe neurodevelopmental outcomes associated with congenital infection compared to infections occurring later during pregnancy.

Objectives: To determine CMV seroprevalence in T1 of pregnancy, its trend, risk factors and the incidence rate of primary infection during pregnancy.

Methods: Using the biobank of the prospective cohort "Grossesse en Santé de Québec" collected between April 2005 and March 2010 at the Québec-Laval Hospital, Québec, Canada, maternal CMV serology was determined using Abbott Architect Chemiluminescence microparticle immunoassays for immunoglobulin G(IgG), immunoglobulin M(IgM) titration and IgG avidity testing. Changepoint detection analysis was used to assess temporal trends. Risk factors associated with seropositivity were determined by multivariable logistic regression.

Results: CMV seroprevalence in T1 of pregnancy was 23.4% (965/4111, 95% CI, 22.1-24.7%). The incidence rate for CMV primary infection during pregnancy was 1.8 (95% CI, 1.2-2.6) per 100 person-years. No changepoint was identified in the maternal CMV-seroprevalence trend. Multivariable analyses showed that T1 maternal CMV seropositivity was associated with having one child OR 1.3 (95% CI, 1.10-1.73) or two or more children OR 1.5 (95%CI, 1.1-2.1), ethnicity other than Caucasian OR 2.1 (95% CI, 1.1-3.8) and country of birth other than Canada and the USA OR 2.8 (95% CI, 1.5-4.9).

Conclusions: In this cohort, maternal seroprevalence in T1 of pregnancy and seroconversion rate were low. This information and identified risk factors could help guide the development and implementation of preventive actions and evidence-based health policies to prevent CMV infection during pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Fig 1
Fig 1. Flowchart of study to detect cytomegalovirus seroprevalence and primary infection among pregnant women of the cohort "Grossesse en santé".
Fig 2
Fig 2. Seroprevalence of CMV in the first trimester of pregnancy over year.
Fig 3
Fig 3. Maternal CMV seroprevalence across all cohort participants from April 2005 to March 2010.
See this image and copyright information in PMC

References

    1. Schleiss MR. Congenital cytomegalovirus: Impact on child health. Contemporary pediatrics. 2018;35(7):16. - PMC - PubMed
    1. Bonalumi S, Trapanese A, Santamaria A, D’Emidio L, Mobili L. Cytomegalovirus infection in pregnancy: review of the literature. Journal of prenatal medicine. 2011;5(1):1. - PMC - PubMed
    1. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Reviews of infectious diseases. 1990;12(Supplement_7):S745–S53. doi: 10.1093/clinids/12.supplement_7.s745 - DOI - PubMed
    1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in medical virology. 2007;17(4):253–76. doi: 10.1002/rmv.535 - DOI - PubMed
    1. Ibrahim S, Siddiqui AA, Siddiqui AR, Ahmed W, Moss PA, Lalani E-NM. Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey. BMC public health. 2016;16(1):1112. doi: 10.1186/s12889-016-3772-8 - DOI - PMC - PubMed

Publication types

MeSH terms

Grants and funding